US FDA greenlights Viridian's eye disease drug
26/06/2026 23:05
US FDA greenlights Viridian's eye disease drug June 26 (Reuters) - The U.S. Food and Drug Administration has approved Viridian Therapeutics' VRDN.O drug to treat patients with thyroid eye disease, the company said on Friday.
(Reporting by Siddhi Mahatole and Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
Recent news on Amgen
See all newsUS RESEARCH ROUNDUP-Apple, Kaiser Aluminum, Reliance
Brief: Amgen Says Imdelltra Combo Reduced Risk Of Death By 58% In First-Line Lung Cancer
Corrected: Amgen drug combined with immunotherapy extends survival in lung cancer trial
US RESEARCH ROUNDUP- Amgen, Lockheed Martin, Norfolk Southern
Eli Lilly hits record high as healthcare stocks rally